PDE3B Gene: Phosphodiesterase 3B

A key regulator of cAMP/cGMP signaling in metabolic and cardiovascular health

Gene Information Card

Symbol PDE3B
Full Name Phosphodiesterase 3B
Gene Type Protein coding
Chromosomal Location 11p15.1
NCBI Gene ID 5140 ncbi.nlm.nih.gov/gene/5140
Ensembl ID ENSG00000152270
UniProt ID Q13370
OMIM ID 602047
HGNC ID 8779
Aliases cGIPDE1, HcGIPDE1

Description

PDE3B encodes phosphodiesterase 3B, an enzyme that hydrolyzes cyclic AMP (cAMP) and cyclic GMP (cGMP), with higher affinity for cAMP. It plays a critical role in regulating intracellular cyclic nucleotide levels, influencing insulin signaling, lipolysis, and cardiac function. PDE3B is expressed in multiple tissues including adipose, liver, and heart, and is implicated in metabolic and cardiovascular diseases.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Type 2 Diabetes Impaired insulin signaling due to altered PDE3B activity affects glucose homeostasis PMID: 15616093
Obesity PDE3B regulates lipolysis; dysregulation contributes to adipocyte dysfunction PMID: 21862674
Heart Failure PDE3B modulates cardiac contractility; inhibition is used therapeutically PMID: 20585035
Cancer Altered PDE3B expression may influence tumor progression via cAMP signaling PMID: 29463868

Expression Profile

Tissue Expression
Tissue nTPM level
Adipose Tissue High High
Liver Medium Medium
Heart Medium Medium
Skeletal Muscle Low Low
Brain Low Low
Cell Line Expression
Cell Line nTPM Notes
HepG2 Medium Liver cancer cell line
3T3-L1 High Adipocyte precursor
HL-1 Medium Cardiac muscle cell line
C2C12 Low Myoblast
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs7528153 SNV 0.15 (global) Intronic; may affect splicing
rs7528153 SNV 0.15 (global) Intronic; may affect splicing
rs7528153 SNV 0.15 (global) Intronic; may affect splicing
rs7528153 SNV 0.15 (global) Intronic; may affect splicing
Mutation functional classification

Loss of Function (LOF)

Rare variants causing reduced PDE3B activity may impair insulin's anti-lipolytic effect, contributing to insulin resistance.

Gain of Function (GOF)

No clear gain-of-function mutations reported; overexpression in some cancers may enhance proliferation.

Dominant Negative (DN)

Not documented for PDE3B.

Gene Ontology (GO)

• 3' • 5'-cyclic-AMP phosphodiesterase activity
• 5'-cyclic-GMP phosphodiesterase activity • cAMP binding
• cGMP binding • metal ion binding
• signal transduction • insulin receptor signaling pathway
• negative regulation of cAMP-mediated signaling

Pathways

• cAMP signaling pathway
• cGMP-PKG signaling pathway
• Insulin signaling pathway
• Adipocytokine signaling pathway

Protein Summary

PDE3B is a membrane-bound phosphodiesterase that preferentially hydrolyzes cAMP, thereby regulating intracellular cAMP levels. It is a key effector of insulin and leptin signaling, controlling lipolysis and glycogenolysis. In the heart, PDE3B contributes to contractility regulation. Its expression is tissue-specific, with high levels in adipose tissue and moderate levels in liver and heart. PDE3B is a therapeutic target for heart failure (e.g., milrinone) and is being explored for metabolic disorders.

Related Products

Product name Cat.No. Species Gene ID
PDE3B Knockout HEK293 Cell Line EDJ-KQ1442 Human 5140 Details Get a Quote
PDE3B Knockout HCT 116 Cell Line EDJ-KQ20988 Human 5140 Details Get a Quote
PDE3B Knockout HeLa Cell Line EDJ-KQ20989 Human 5140 Details Get a Quote
PDE3B Knockout A-549 Cell Line EDJ-KQ19653 Human 5140 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
How did you hear about us: